Table 5.
Budget impact analyses of cervical cancer screening using HPV DNA testing in women aged 25–65
| BIA | # of women eligible for screening |
# of women screened | % screened | # of T- women | # of T + women | # of total screening | % of TAH | Total BIA (million THB) | Average per year (million THB) | |
|---|---|---|---|---|---|---|---|---|---|---|
| Clinician- and self-collected samples for HPV DNA testing [screening age 25–65 years] | ||||||||||
| 5 years | 21 657 104 | 16 785 188 | 77.5% | 14 722 180 | 2 063 008 | 18 524 540 | 2.6% | ฿ 6688 | ฿ 1338 | |
| 10 years | 23 622 356 | 18 308 343 | 77.5% | 16 058 129 | 2 250 213 | 38 135 036 | 5.1% | ฿ 13 765 | ฿ 1377 | |
| Clinician-collected samples for HPV DNA testing | ||||||||||
| 5 years | 7 287 295 | 7 287 295 | 33.6% | 6 314 539 | 972 756 | 8 113 118 | 2.9% | ฿ 3384 | ฿ 677 | |
| 10 years | 7 948 573 | 7 948 573 | 33.6% | 6 887 546 | 1 061 028 | 16 675 645 | 5.6% | ฿ 6956 | ฿ 696 | |
| Self-collected samples for HPV DNA testing | ||||||||||
| 5 years | 14 369 809 | 9 497 893 | 43.9% | 8 407 641 | 1 090 252 | 10 411 422 | 2.4% | ฿ 3304 | ฿ 661 | |
| 10 years | 15 673 782 | 10 359 769 | 43.9% | 9 170 583 | 1 189 186 | 21 459 391 | 4.8% | ฿ 6810 | ฿ 681 | |
#, number; BIA, budget impact analyses; HPV DNA, human papillomavirus deoxyribonucleic acid; TAH, total abdominal hysterectomy; THB, Thai baht; T+, test positive; T-, test negative